NCT05099731

Brief Summary

The application of point-of-care test with oral fluid-based biomarkers assisting in early-detection of gum disease is highly needed. Recently, a commercially available active Matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) for detecting the risk of gum disease has been developed. Currently, there is a paucity of research to assess the performance of aMMP-8 POCT using different oral fluid sampling methods. This study will evaluate the accuracy of aMMP-8 POCT for discriminating periodontal health from disease in saliva and oral rinse.The information obtained from this study may help us understand better which sample is superior for the early detection of gum disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2021

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

October 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 29, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

March 31, 2022

Status Verified

March 1, 2022

Enrollment Period

3 months

First QC Date

October 26, 2021

Last Update Submit

March 29, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • The area under the receiver operating characteristic curve (AUROC) measure

    Comparing the area under the receiver operating characteristic curve (AUROC) of aMMP-8 in different samples to correctly identify periodontitis cases at the time of completion of clinical examination

    1day

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consenting untreated patients seeking care at the Periodontology clinic and Implant Dentistry clinic of Shanghai Ninth People's Hospital.

You may qualify if:

  • Aged 18 and above
  • Ability and willingness to give written informed consent

You may not qualify if:

  • Edentulous mouth
  • Pregnant females
  • Having received professional periodontal treatment (other than supragingival cleaning) within the previous 12 months
  • Having received antibiotic medication within the previous 3 months
  • Presence of xerostomia interfering with saliva sampling
  • Inability or unwillingness of individual to give written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Oral and Maxillofacial Implantology

Shanghai, Shanghai Municipality, 200000, China

Location

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 26, 2021

First Posted

October 29, 2021

Study Start

October 10, 2021

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

March 31, 2022

Record last verified: 2022-03

Locations